Angus Dalgleish qualified in medicine from University College London and trained in internal medicine and medical oncology in Brisbane and Sydney. He did his MD with Professor Robin Weiss at the ICR before becoming a Senior Clinical Fellow at the MRC Clinical Research Centre. Since 1992 he has been Professor of Oncology at St. George’s. He has over 370 publications and has co-authored 5 books and been an editorial member of many oncology and immunology journals.
Dr. Pirouz M Daftarian is a cellular and molecular immunologist with 20-year experience in Immuno-Oncology and vaccinology. Pirouz has led and shepherded R&D operations of two vaccine biotech companies, has served as a faculty of the Miller School of Medicine, acted as DOD and NIH intramural reviewer for vaccine and immune-oncology (IO) proposals, and is the principal inventor of several vaccine and IO related regular patents. He has authored more than 50 research papers in peer reviewed scientific journals and is an invited speaker to many vaccine and IO conferences. Pirouz has completed his PhD in the University of Ottawa, a postdoctoral fellowship on cancer biology and vaccines in the City of Hope National Medical Center, and has served in academia (University of Dalhousie and Miller School of Medicine University of Miami) and industry (NGM Biopharmaceutical, Immunovaccine, Nanovax). Dr. Daftarian is currently working as an Application Manager in MBL International leading a team of scientists to develop modern research tools and biomarkers for the development of immunetherapeutics and vaccines.
She had her Bachelor of Veterinary Medical science Cairo University 1992, MSc of Virology Cairo University 1999 and PhD in Virology Cairo University2004. She promoted to Associate professor in 2009 then to Professor of Virology and Immunology 2014 at the National Research Centre (NRC). She has a special interest in Molecular Virology; currently she is working on several viruses which cause great economic losses such as FMD, BVD, ND, IB, ILT and reemerging viral diseases such as Bluetongue. In addition, she has several researches on diagnosis and control of these viruses. She has been principle investigator for many projects funded by NRC and STDF. She has supervised many MSc and PhD thesis and a chief Editor in many national and international Journals; she is also a member of many national and international specified associations. She is a member of the Biosafety and Biorisk committee and CEO of the Virology Unit in the Department of Microbiology at the NRC.